Beranda › Kanker Darah › New Jersey › Edison
Uji klinis Kanker Darah di Edison, NJ
13 studi untuk Kanker Darah mencari peserta di lokasi sekitar Edison (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Menerima pesertaFase 3
- Cancer Institute of New Jersey ( Site 0025), New Brunswick · 3 mi jauhnya
Rutgers University Study of the Genetics of Blood Cancers
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Rutgers University, Piscataway · 2 mi jauhnya
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Menerima pesertaFase 1
- Rutgers Cancer Institute of New Jersey, Piscataway · 2 mi jauhnya
Genomic Profiling in Cancer Patients
Menerima pesertaStudi observasional
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauhnya
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Menerima pesertaFase 2
- Astera Cancer Care ( Site 2732), East Brunswick · 6 mi jauhnya
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Menerima pesertaFase 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi jauhnya
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Menerima pesertaFase 1
- START New Jersey, East Brunswick · 6 mi jauhnya
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Menerima pesertaFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Menerima pesertaStudi observasional
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi jauhnya
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Menerima pesertaFase 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauhnya
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Menerima pesertaSukarelawan sehat diterima
- Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge · 15 mi jauhnya
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Menerima pesertaFase 1
- Rutgers Cancer Institute, New Brunswick · 3 mi jauhnya
Uji klinis Kanker Darah di kota lain
- Houston, TX46 studi
- New York City, NY26 studi
- Boston, MA25 studi
- Washington, DC19 studi
- Baltimore, MD18 studi
- Seattle, WA18 studi
- Los Angeles, CA17 studi
- Durham, NC16 studi
- Chicago, IL15 studi
- Philadelphia, PA14 studi
- Atlanta, GA13 studi
- Nashville, TN13 studi
Studi lain di Edison
- Kanker Payudara68 studi
- Kanker Paru Non-Sel Kecil47 studi
- Kanker (semua jenis)33 studi
- Kanker Prostat29 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Mieloma Multipel22 studi
- Kanker Kandung Kemih21 studi
- Kanker Metastatik20 studi
- Kanker Ovarium20 studi
- Leukemia Mieloid Akut20 studi
- Kanker Endometrium19 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.